Funding partnerships ICRF pursues expansion through partnerships with other foundations and nonprofits (evidenced by recent collaborations with Lung Cancer Research Foundation and Sharsheret). There is an opportunity to propose joint funding initiatives, sponsor-driven research programs, or co-funded grants with aligned mission partners.

Immunotherapy focus ICRF-supported research includes immunotherapy and targeted therapies. Sales opportunities exist in offering specialized grant programs, corporate sponsorships for immuno-oncology initiatives, or sponsorship of symposiums and training focused on cutting-edge cancer therapies.

Global chapter network With active chapters across the U.S., Canada, and Israel, there is scope for regional partnerships, event co-hosting, and donor engagement programs that leverage local networks to raise awareness and funds for Israeli cancer research projects.

Independent grant model ICRF awards funds directly to researchers without overhead reductions, highlighting a donor-value proposition. This favors services that support grant administration, donor reporting platforms, and transparency tools that streamline impact tracking for major gifts.

Financial scale Annual revenue estimated at 10–25 million and a history of multi-million fundraising events suggest opportunities for enterprise sponsorships, corporate giving programs, and strategic philanthropy packages tailored to large donors and corporate partners in the life sciences sector.